GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | 11/6/2026 3:03:28 PM | Small | View | Financials | 10-Q | SEC | 3Q 2026 ending: 9/30/2026 | Rev: $30,594,000 +10.0% | Assets $189,600,000 | EPS -$0.02 | |
| Anika Therapeutics, Inc. (ANIK) | 11/6/2026 7:21:34 AM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $30,594,000 +10.0% | Assets $189,600,000 | EPS -$0.02 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 7/29/2026 4:11:30 PM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $32,610,000 +15.6% | Assets $183,474,000 | EPS $0.24 | |
| Anika Therapeutics, Inc. (ANIK) | 7/29/2026 7:21:31 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $32,610,000 +15.6% | Assets $183,474,000 | EPS $0.24 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 4/30/2026 6:25:12 AM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $29,612,000 +13.2% | Assets $179,387,000 | EPS -$0.37 | |
| Anika Therapeutics, Inc. (ANIK) | 4/29/2026 7:21:27 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $29,612,000 +13.2% | Assets $179,387,000 | EPS -$0.37 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 4/28/2026 4:53:36 PM | View | Proxy | SEC | Y 2025 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 3/3/2026 6:15:18 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $112,819,000 -5.9% | Assets $190,270,000 | EPS -$0.76 | |
| Anika Therapeutics, Inc. (ANIK) | 2/26/2026 7:19:19 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $30,615,000 | Assets $190,270,000 | EPS $0.02 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 11/5/2025 4:12:50 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $27,817,000 -28.2% | Assets $189,437,000 | EPS -$0.16 | |
| Anika Therapeutics, Inc. (ANIK) | 11/5/2025 7:21:59 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $27,817,000 -28.2% | Assets $189,437,000 | EPS -$0.16 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 7/30/2025 4:22:54 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $28,219,000 -32.7% | Assets $187,682,000 | EPS -$0.28 | |
| Anika Therapeutics, Inc. (ANIK) | 7/30/2025 7:21:23 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $28,219,000 -32.7% | Assets $187,682,000 | EPS -$0.28 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 5/9/2025 2:44:43 PM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $26,168,000 -35.4% | Assets $190,605,000 | EPS -$0.34 | |
| Anika Therapeutics, Inc. (ANIK) | 5/9/2025 7:21:14 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $26,168,000 -35.4% | Assets $190,605,000 | EPS -$0.34 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 4/28/2025 5:26:59 PM | View | Proxy | SEC | Y 2024 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 3/17/2025 6:16:28 AM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $119,907,000 -28.1% | Assets $202,740,000 | EPS -$3.83 | |
| Anika Therapeutics, Inc. (ANIK) | 3/12/2025 4:12:45 PM | View | Financials | Earnings | SEC | Y 2024 | Rev ($1,290,000) | Assets $202,740,000 | EPS -$1.49 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 11/4/2024 4:50:53 PM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $38,753,000 -6.5% | Assets $231,405,000 | EPS -$2.03 | |
| Anika Therapeutics, Inc. (ANIK) | 10/31/2024 7:21:12 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $38,753,000 -6.5% | Assets $231,405,000 | EPS -$2.03 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 8/8/2024 5:39:14 PM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $41,921,000 -5.4% | Assets $262,655,000 | EPS -$0.01 | |
| Anika Therapeutics, Inc. (ANIK) | 8/8/2024 4:19:01 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $41,921,000 -5.4% | Assets $262,655,000 | EPS -$0.01 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 6/11/2024 5:06:28 PM | View | Proxy | SEC | Y 2023 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 5/8/2024 5:26:40 PM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $40,523,000 +6.9% | Assets $263,744,000 | EPS -$0.31 | |
| Anika Therapeutics, Inc. (ANIK) | 5/8/2024 4:17:57 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $40,523,000 +6.9% | Assets $263,744,000 | EPS -$0.31 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 4/26/2024 8:59:12 AM | Small | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Rev: $166,662,000 +6.7% | Assets $270,632,000 | EPS -$5.64 | |
| Anika Therapeutics, Inc. (ANIK) | 3/15/2024 12:40:21 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $166,662,000 +6.7% | Assets $270,632,000 | EPS -$5.64 | |
| Anika Therapeutics, Inc. (ANIK) | 3/13/2024 4:12:05 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $42,971,000 +8.5% | Assets $270,632,000 | EPS -$4.30 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 11/3/2023 6:15:22 AM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $41,465,000 +3.0% | Assets $328,158,000 | EPS -$0.45 | |
| Anika Therapeutics, Inc. (ANIK) | 11/2/2023 4:12:34 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $41,465,000 +3.0% | Assets $328,158,000 | EPS -$0.45 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 8/8/2023 5:28:24 PM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $44,302,000 +11.7% | Assets $328,882,000 | EPS -$0.19 | |
| Anika Therapeutics, Inc. (ANIK) | 8/8/2023 4:14:16 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $44,302,000 +11.7% | Assets $328,882,000 | EPS -$0.19 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 5/9/2023 5:31:17 PM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $37,924,000 +3.4% | Assets $339,074,000 | EPS -$0.71 | |
| Anika Therapeutics, Inc. (ANIK) | 5/9/2023 4:21:20 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $37,924,000 +3.4% | Assets $339,074,000 | EPS -$0.71 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 5/1/2023 5:20:51 PM | View | Proxy | SEC | Y 2022 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 3/16/2023 3:47:39 PM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $156,236,000 +5.7% | Assets $349,128,000 | EPS -$1.02 | |
| Anika Therapeutics, Inc. (ANIK) | 3/6/2023 4:12:32 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $39,622,000 +10.6% | Assets $349,128,000 | EPS -$0.34 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 11/9/2022 2:47:29 PM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $40,264,000 +1.8% | Assets $347,746,000 | EPS -$0.29 | |
| Anika Therapeutics, Inc. (ANIK) | 11/8/2022 4:16:40 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $40,264,000 +1.8% | Assets $347,746,000 | EPS -$0.29 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 8/4/2022 5:09:41 PM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $39,657,000 +4.0% | Assets $354,123,000 | EPS -$0.20 | |
| Anika Therapeutics, Inc. (ANIK) | 8/3/2022 4:15:43 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $39,657,000 +4.0% | Assets $354,123,000 | EPS -$0.20 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 6/1/2022 12:03:03 PM | View | Proxy | SEC | Y 2021 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 5/6/2022 6:08:20 AM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $36,693,000 +7.0% | Assets $342,239,000 | EPS -$0.20 | |
| Anika Therapeutics, Inc. (ANIK) | 5/5/2022 4:11:22 PM | View | Financials | Earnings | WIRE | 1Q 2022 | Rev $36,693,000 +7.0% | Assets $342,239,000 | EPS -$0.20 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 4/27/2022 5:25:39 PM | View | Proxy | SEC | Y 2021 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 3/11/2022 6:12:01 AM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $147,794,000 +13.3% | Assets $347,535,000 | EPS $0.28 | |
| Anika Therapeutics, Inc. (ANIK) | 3/8/2022 4:41:56 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $35,821,000 +9.6% | Assets $347,535,000 | EPS -$0.40 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 11/5/2021 6:12:52 AM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $39,536,000 +24.7% | Assets $352,930,000 | EPS $0.04 | |
| Anika Therapeutics, Inc. (ANIK) | 11/4/2021 4:32:45 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $39,536,000 +24.7% | Assets $352,930,000 | EPS $0.04 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 8/6/2021 6:11:47 AM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $38,145,000 +24.3% | Assets $363,131,000 | EPS $0.45 | |
| Anika Therapeutics, Inc. (ANIK) | 8/5/2021 4:27:56 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $38,145,000 +24.3% | Assets $363,131,000 | EPS $0.45 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 5/7/2021 6:11:21 AM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $34,292,000 -3.1% | Assets $362,253,000 | EPS $0.20 | |
| Anika Therapeutics, Inc. (ANIK) | 5/6/2021 4:27:09 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $34,292,000 -3.1% | Assets $362,253,000 | EPS $0.20 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 4/30/2021 4:34:15 PM | View | Proxy | SEC | Y 2020 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 4/26/2021 5:03:10 PM | Small | View | Financials | 10-K/A | SEC | Y 2020 ending: 12/31/2020 | Rev: $130,457,000 +13.8% | Assets $365,605,000 | EPS -$1.69 | |
| Anika Therapeutics, Inc. (ANIK) | 3/5/2021 5:21:37 PM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $130,457,000 +13.8% | Assets $365,605,000 | EPS -$1.69 | |
| Anika Therapeutics, Inc. (ANIK) | 3/4/2021 4:12:14 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $32,688,000 +9.8% | Assets $365,605,000 | EPS -$1.10 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 11/5/2020 6:13:21 AM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $31,694,000 +6.7% | Assets $416,338,000 | EPS -$0.45 | |
| Anika Therapeutics, Inc. (ANIK) | 11/4/2020 4:15:02 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $31,694,000 +6.7% | Assets $416,338,000 | EPS -$0.45 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 8/7/2020 9:49:12 AM | Small | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $30,678,000 +0.9% | Assets $440,525,000 | EPS -$0.54 | |
| Anika Therapeutics, Inc. (ANIK) | 7/30/2020 6:51:35 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $30,678,000 +0.9% | Assets $440,525,000 | EPS -$0.54 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 5/22/2020 5:03:59 PM | Small | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $35,397,000 +43.2% | Assets $398,913,000 | EPS $0.40 | |
| Anika Therapeutics, Inc. (ANIK) | 5/7/2020 4:10:48 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $35,397,000 +43.2% | Assets $398,913,000 | EPS $0.40 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 4/29/2020 4:09:16 PM | View | Proxy | SEC | Y 2019 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 4/23/2020 4:10:42 PM | View | Financials | Earnings | WIRE | 1Q 2020 | Rev $35,397,000 +43.2% | Assets $398,913,000 | EPS $0.40 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 3/6/2020 6:14:04 AM | Small | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $114,610,000 +8.6% | Assets $330,710,000 | EPS $1.89 | |
| Anika Therapeutics, Inc. (ANIK) | 2/20/2020 4:06:28 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $29,772,000 +10.4% | Assets $330,710,000 | EPS $0.28 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 2/6/2020 4:10:58 PM | View | Financials | Earnings | WIRE | Y 2019 | Rev $29,772,000 +10.4% | Assets $330,710,000 | EPS $0.28 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 10/28/2019 5:45:38 PM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $29,697,000 +10.9% | Assets $319,579,000 | EPS $0.66 | |
| Anika Therapeutics, Inc. (ANIK) | 10/24/2019 4:10:41 PM | View | Financials | Earnings | WIRE | 3Q 2019 | Rev $29,697,000 +10.9% | Assets $319,579,000 | EPS $0.66 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 7/26/2019 5:21:50 PM | Small | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $30,418,000 -0.4% | Assets $287,364,000 | EPS $0.67 | |
| Anika Therapeutics, Inc. (ANIK) | 7/24/2019 4:07:40 PM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $30,418,000 -0.4% | Assets $287,364,000 | EPS $0.67 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 5/6/2019 6:13:26 AM | Small | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $24,723,000 +16.3% | Assets $306,659,000 | EPS $0.31 | |
| Anika Therapeutics, Inc. (ANIK) | 5/2/2019 4:09:27 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $24,723,000 +16.3% | Assets $306,659,000 | EPS $0.31 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 4/25/2019 4:12:17 PM | View | Proxy | SEC | Y 2018 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 2/27/2019 6:39:28 AM | Small | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $105,555,000 -6.9% | Assets $278,993,000 | EPS $1.27 | |
| Anika Therapeutics, Inc. (ANIK) | 2/21/2019 4:09:02 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $26,956,000 -8.3% | Assets $278,993,000 | EPS $0.54 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 10/26/2018 4:34:07 PM | Small | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $26,787,000 -1.5% | Assets $269,264,000 | EPS $0.53 | |
| Anika Therapeutics, Inc. (ANIK) | 10/24/2018 4:09:05 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $26,787,000 -1.5% | Assets $269,264,000 | EPS $0.53 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 7/31/2018 5:36:10 PM | Small | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $30,548,000 -8.7% | Assets $265,413,000 | EPS $0.68 | |
| Anika Therapeutics, Inc. (ANIK) | 7/25/2018 4:09:35 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $30,548,000 -8.7% | Assets $265,413,000 | EPS $0.68 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 5/10/2018 2:14:02 PM | Small | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $21,264,000 -9.1% | Assets $284,336,000 | EPS -$0.46 | |
| Anika Therapeutics, Inc. (ANIK) | 5/2/2018 4:09:14 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $21,264,000 -9.1% | Assets $284,336,000 | EPS -$0.46 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 4/17/2018 4:07:07 PM | View | Proxy | SEC | Y 2017 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 2/27/2018 6:13:37 AM | Small | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $113,420,000 +9.7% | Assets $282,617,000 | EPS $2.11 | |
| Anika Therapeutics, Inc. (ANIK) | 2/21/2018 5:50:57 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $29,388,000 +2.3% | Assets $282,617,000 | EPS $0.53 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 10/27/2017 5:13:33 PM | Small | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $27,184,000 +5.4% | Assets $273,132,000 | EPS $0.46 | |
| Anika Therapeutics, Inc. (ANIK) | 10/25/2017 4:06:22 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $27,184,000 +5.4% | Assets $273,132,000 | EPS $0.46 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 7/28/2017 4:12:53 PM | Small | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $33,462,000 +25.9% | Assets $265,004,000 | EPS $0.76 | |
| Anika Therapeutics, Inc. (ANIK) | 7/26/2017 4:05:55 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $33,462,000 +25.9% | Assets $265,004,000 | EPS $0.76 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 5/4/2017 4:54:48 PM | Small | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $23,386,000 +4.9% | Assets $247,367,000 | EPS $0.37 | |
| Anika Therapeutics, Inc. (ANIK) | 5/3/2017 4:05:47 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $23,386,000 +4.9% | Assets $247,367,000 | EPS $0.37 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 4/28/2017 4:10:17 PM | View | Proxy | SEC | Y 2016 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 2/24/2017 5:07:11 PM | Small | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $103,379,000 +11.2% | Assets $240,246,000 | EPS $2.15 | |
| Anika Therapeutics, Inc. (ANIK) | 2/15/2017 4:05:38 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $28,726,000 -7.0% | Assets $240,246,000 | EPS $0.54 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 11/1/2016 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $25,789,000 +8.9% | Assets $231,062,000 | EPS $0.59 | |
| Anika Therapeutics, Inc. (ANIK) | 10/26/2016 4:05:23 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $25,789,000 +8.9% | Assets $231,062,000 | EPS $0.59 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 8/1/2016 4:42:00 PM | Small | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $26,581,000 +16.1% | Assets $222,738,000 | EPS $0.57 | |
| Anika Therapeutics, Inc. (ANIK) | 7/27/2016 4:07:50 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $26,581,000 +16.1% | Assets $222,738,000 | EPS $0.57 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 5/3/2016 4:06:15 PM | Small | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $22,283,000 +43.6% | Assets $214,457,000 | EPS $0.45 | |
| Anika Therapeutics, Inc. (ANIK) | 4/27/2016 4:06:21 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $22,283,000 +43.6% | Assets $214,457,000 | EPS $0.45 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 4/20/2016 4:05:13 PM | View | Proxy | SEC | Y 2015 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 3/10/2016 9:01:27 AM | Small | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $92,999,000 -11.9% | Assets $235,748,000 | EPS $2.01 | |
| Anika Therapeutics, Inc. (ANIK) | 2/24/2016 4:06:08 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $30,894,000 +32.8% | Assets $235,748,000 | EPS $0.72 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 11/3/2015 4:06:13 PM | Small | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $23,681,000 +7.4% | Assets $222,850,707 | EPS $0.55 | |
| Anika Therapeutics, Inc. (ANIK) | 10/28/2015 4:08:17 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $23,681,000 +7.4% | Assets $222,850,707 | EPS $0.55 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 8/4/2015 4:23:45 PM | Small | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $22,904,000 -12.8% | Assets $208,012,150 | EPS $0.51 | |
| Anika Therapeutics, Inc. (ANIK) | 7/29/2015 5:01:26 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $22,904,000 -12.8% | Assets $208,012,150 | EPS $0.51 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 5/4/2015 4:05:40 PM | Small | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $15,520,000 -54.4% | Assets $197,684,906 | EPS $0.23 | |
| Anika Therapeutics, Inc. (ANIK) | 4/23/2015 4:33:27 PM | View | Proxy | SEC | Y 2014 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 4/23/2015 4:05:14 PM | View | Proxy | SEC | Y 2014 | ||||||
| Anika Therapeutics, Inc. (ANIK) | 3/13/2015 3:16:28 PM | Small | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $105,595,000 +40.6% | Assets $192,808,000 | EPS $2.51 | |
| Anika Therapeutics, Inc. (ANIK) | 2/25/2015 4:05:39 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $23,255,000 +9.4% | Assets $192,808,000 | EPS $0.51 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 11/6/2014 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $22,055,000 +24.2% | Assets $185,497,590 | EPS $0.40 | |
| Anika Therapeutics, Inc. (ANIK) | 10/29/2014 4:05:38 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $22,055,000 +24.2% | Assets $185,497,590 | EPS $0.40 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 8/4/2014 5:23:29 PM | Small | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $26,275,000 +26.2% | Assets $179,096,694 | EPS $0.60 | |
| Anika Therapeutics, Inc. (ANIK) | 7/30/2014 4:05:56 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $26,275,000 +26.2% | Assets $179,096,694 | EPS $0.60 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 5/5/2014 5:27:31 PM | Small | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $34,010,000 +123.1% | Assets $174,061,246 | EPS $0.97 | |
| Anika Therapeutics, Inc. (ANIK) | 4/29/2014 4:07:02 PM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $34,010,000 +123.1% | Assets $174,061,246 | EPS $0.97 | Export Earnings Model | |
| Anika Therapeutics, Inc. (ANIK) | 4/23/2014 3:48:36 PM | View | Proxy | SEC | Y 2013 | ||||||
| ANIKA THERAPEUTICS INC (ANIK) | 3/13/2014 5:27:09 PM | Small | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $75,081,000 +5.2% | Assets $156,041,881 | EPS $1.39 | |
| ANIKA THERAPEUTICS INC (ANIK) | 2/26/2014 4:12:27 PM | View | Financials | Earnings | SEC | Y 2013 | Rev $21,251,328 -6.0% | Assets $156,041,881 | EPS $0.44 | Export Earnings Model | |
| ANIKA THERAPEUTICS INC (ANIK) | 11/5/2013 4:06:10 PM | Small | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $17,754,438 +20.2% | Assets $156,882,524 | EPS $0.33 | |
| ANIKA THERAPEUTICS INC (ANIK) | 10/30/2013 4:05:50 PM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $17,754,438 +20.2% | Assets $156,882,524 | EPS $0.33 | Export Earnings Model | |
| ANIKA THERAPEUTICS INC (ANIK) | 8/6/2013 5:19:45 PM | Small | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $20,828,377 +6.1% | Assets $148,394,650 | EPS $0.40 | |
| ANIKA THERAPEUTICS INC (ANIK) | 7/31/2013 4:31:43 PM | View | Financials | Earnings | SEC | 2Q 2013 | Rev $20,828,377 +6.1% | Assets $148,394,650 | EPS $0.40 | Export Earnings Model | |
| ANIKA THERAPEUTICS INC (ANIK) | 5/6/2013 4:35:10 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $15,247,011 +6.2% | Assets $141,358,366 | EPS $0.21 | |
| ANIKA THERAPEUTICS INC (ANIK) | 5/1/2013 6:14:58 PM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $15,247,011 +6.2% | Assets $141,358,366 | EPS $0.21 | Export Earnings Model | |
| ANIKA THERAPEUTICS INC (ANIK) | 4/23/2013 4:02:28 PM | View | Proxy | SEC | Y 2012 | ||||||
| ANIKA THERAPEUTICS INC (ANIK) | 3/14/2013 5:30:00 AM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $71,358,505 +10.2% | Assets $142,069,051 | EPS $0.82 | |
| ANIKA THERAPEUTICS INC (ANIK) | 2/27/2013 5:08:38 PM | View | Financials | Earnings | SEC | Y 2012 | Rev $22,606,465 +22.6% | Assets $142,069,051 | EPS $0.31 | Export Earnings Model | |
| ANIKA THERAPEUTICS INC (ANIK) | 1/22/2013 9:33:30 AM | View | Financials | Earnings (Prelim) | SEC | Y 2012 | Export Earnings Model | ||||
| ANIKA THERAPEUTICS INC (ANIK) | 11/8/2012 3:40:18 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $14,766,611 -20.0% | Assets $134,872,136 | EPS $0.11 | |
| ANIKA THERAPEUTICS INC (ANIK) | 10/30/2012 4:30:43 PM | View | Financials | Earnings | SEC | 3Q 2012 | Rev $14,766,611 -20.0% | Assets $134,872,136 | EPS $0.11 | Export Earnings Model | |
| ANIKA THERAPEUTICS INC (ANIK) | 8/7/2012 4:07:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $19,624,769 +21.6% | Assets $136,375,599 | EPS $0.26 | |
| ANIKA THERAPEUTICS INC (ANIK) | 8/2/2012 2:27:06 PM | View | Financials | Earnings | SEC | 2Q 2012 | Rev $19,624,769 +21.6% | Assets $136,375,599 | EPS $0.26 | Export Earnings Model | |
| ANIKA THERAPEUTICS INC (ANIK) | 5/7/2012 4:55:49 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $14,360,660 +22.3% | Assets $133,228,507 | EPS $0.14 | |
| ANIKA THERAPEUTICS INC (ANIK) | 5/3/2012 5:21:07 PM | View | Financials | Earnings | SEC | 1Q 2012 | Rev $14,360,660 +22.3% | Assets $133,228,507 | EPS $0.14 | Export Earnings Model | |
| ANIKA THERAPEUTICS INC (ANIK) | 4/25/2012 4:24:12 PM | View | Proxy | SEC | Y 2011 | ||||||
| ANIKA THERAPEUTICS INC (ANIK) | 3/13/2012 9:44:00 AM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $64,778,635 +16.6% | Assets $132,844,434 | EPS $0.62 | |
| ANIKA THERAPEUTICS INC (ANIK) | 2/29/2012 6:05:13 PM | View | Financials | Earnings | SEC | Y 2011 | Rev $18,444,287 +25.3% | Assets $132,844,434 | EPS $0.21 | Export Earnings Model | |
| ANIKA THERAPEUTICS INC (ANIK) | 11/4/2011 4:18:07 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $18,455,817 +33.1% | Assets $129,780,051 | EPS $0.22 | |
| ANIKA THERAPEUTICS INC (ANIK) | 11/2/2011 4:16:49 PM | View | Financials | Earnings | SEC | 3Q 2011 | Rev $18,455,817 +33.1% | Assets $129,780,051 | EPS $0.22 | Export Earnings Model | |
| ANIKA THERAPEUTICS INC (ANIK) | 8/10/2011 4:26:04 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $16,140,852 +11.3% | Assets $131,392,567 | EPS $0.17 | |
| ANIKA THERAPEUTICS INC (ANIK) | 8/4/2011 4:36:18 PM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $16,140,852 +11.3% | Assets $131,392,567 | EPS $0.17 | Export Earnings Model | |
| ANIKA THERAPEUTICS INC (ANIK) | 5/4/2011 8:57:46 PM | View | Financials | Earnings | SEC | 1Q 2011 | Rev $11,737,679 | EPS $0.02 | Export Earnings Model | ||
| ANIKA THERAPEUTICS INC (ANIK) | 4/28/2011 5:25:12 PM | View | Proxy | SEC | Y 2010 | ||||||
| ANIKA THERAPEUTICS INC (ANIK) | 3/9/2011 6:55:45 PM | View | Financials | Earnings | SEC | Y 2010 | Rev $14,721,493 | Assets $128,936,868 | EPS $0.10 | Export Earnings Model | |
| ANIKA THERAPEUTICS INC (ANIK) | 11/8/2010 5:08:28 PM | View | Financials | Earnings | SEC | 3Q 2010 | Rev $13,869,214 | EPS $0.09 | Export Earnings Model | ||
| ANIKA THERAPEUTICS INC (ANIK) | 8/9/2010 6:52:10 PM | View | Financials | Earnings | SEC | 2Q 2010 | Rev $14,499,800 | EPS $0.08 | Export Earnings Model | ||
| ANIKA THERAPEUTICS INC (ANIK) | 5/10/2010 5:25:40 PM | View | Financials | Earnings | SEC | 1Q 2010 | Export Earnings Model | ||||
| ANIKA THERAPEUTICS INC (ANIK) | 4/22/2010 4:04:02 PM | View | Proxy | SEC | Y 2009 | ||||||
| ANIKA THERAPEUTICS INC (ANIK) | 3/17/2010 6:04:22 AM | View | Financials | Earnings | SEC | Y 2009 | Export Earnings Model | ||||
| ANIKA THERAPEUTICS INC (ANIK) | 10/27/2009 4:21:12 PM | View | Financials | Earnings | SEC | 3Q 2009 | Export Earnings Model | ||||
| ANIKA THERAPEUTICS INC (ANIK) | 7/22/2009 4:53:45 PM | View | Financials | Earnings | SEC | 2Q 2009 | Export Earnings Model | ||||
| ANIKA THERAPEUTICS INC (ANIK) | 4/29/2009 6:50:36 PM | View | Financials | Earnings | SEC | 1Q 2009 | Export Earnings Model | ||||
| ANIKA THERAPEUTICS INC (ANIK) | 4/28/2009 4:15:22 PM | View | Proxy | SEC | Y 2008 | ||||||
| ANIKA THERAPEUTICS INC (ANIK) | 3/5/2009 5:27:15 PM | View | Financials | Earnings | SEC | Y 2008 | Export Earnings Model |